Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-10-08

FDA Approved: BUPRENORPHINE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s original application for buprenorphine, a generic opioid medication, under the ANDA pathway. This marks the availa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

ORIG AP for BUPRENORPHINE (BUPRENORPHINE)